Fresenius Kabi Oncology 483, Jan 2013

Fresenius Kabi Oncology 483, Jan 2013

Peter Baker FDA$119.00

FDA investigators audited the Fresenius Kabi Oncology facility in Nadia, India and issued inspectional observations (via FDA 483) on 18 Jan 2013.

Buy This DocumentBuy 1-Year 483 Access

Product details

  • Inspection end: 18 Jan 2013
  • Location: Nadia, India